ly 274614 has been researched along with haloperidol in 1 studies
Studies (ly 274614) | Trials (ly 274614) | Recent Studies (post-2010) (ly 274614) | Studies (haloperidol) | Trials (haloperidol) | Recent Studies (post-2010) (haloperidol) |
---|---|---|---|---|---|
96 | 0 | 15 | 20,330 | 1,753 | 3,294 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Awere, S; Blackman, A; Leander, JD; Moore, NA | 1 |
1 other study(ies) available for ly 274614 and haloperidol
Article | Year |
---|---|
NMDA receptor antagonists inhibit catalepsy induced by either dopamine D1 or D2 receptor antagonists.
Topics: Animals; Benzamides; Benzazepines; Catalepsy; Chlordiazepoxide; Dizocilpine Maleate; Dopamine D2 Receptor Antagonists; Haloperidol; Isoquinolines; Male; Rats; Receptors, Dopamine D1; Receptors, N-Methyl-D-Aspartate | 1993 |